Literature DB >> 17346545

Progesterone protects fetal chorion and maternal decidua cells from calcium-induced death.

Amy P Murtha1, Liping Feng, Bryan Yonish, Phyllis C Leppert, David W Schomberg.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether progesterone exerts a protective effect in chorion and decidua cells when exposed to calcimycin. STUDY
DESIGN: Fetal membrane samples were collected from term elective repeat cesarean deliveries and chorion and decidua cells that are separated and cultured. Cells were pretreated with progesterone and exposed to calcimycin. Cell viability was determined, and percent cell viability was calculated.
RESULTS: Exposure to calcimycin resulted in a reduction of cell viability in both chorion and decidua cells in a dose-dependent fashion. In chorion and decidua cells, progesterone pretreatment followed by calcimycin increased cell viability compared with calcimycin treatment alone (chorion, 67%, vs controls, 24%; P < .001; decidua, 58%, vs controls, 35%; P < .001). The progesterone receptor antagonist, RTI 6413-49a, blocked the protective effect of progesterone in both chorion and decidua cells.
CONCLUSION: These preliminary results suggest that progesterone may provide a protective effect in fetal membrane cells and that this effect may be mediated through the progesterone receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346545     DOI: 10.1016/j.ajog.2007.01.007

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Placental inflammation and oxidative stress in the mouse model of assisted reproduction.

Authors:  J M Raunig; Y Yamauchi; M A Ward; A C Collier
Journal:  Placenta       Date:  2011-09-01       Impact factor: 3.481

Review 2.  Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.

Authors:  Maisa Feghali; Raman Venkataramanan; Steve Caritis
Journal:  Semin Perinatol       Date:  2014-09-23       Impact factor: 3.300

3.  Progesterone receptor membrane components: key regulators of fetal membrane integrity.

Authors:  Violetta Lozovyy; Lauren Richardson; George Saade; Ramkumar Menon
Journal:  Biol Reprod       Date:  2021-02-11       Impact factor: 4.285

4.  Assisted reproduction technologies alter steroid delivery to the mouse fetus during pregnancy.

Authors:  Jefferey M Raunig; Yasuhiro Yamauchi; Monika A Ward; Abby C Collier
Journal:  J Steroid Biochem Mol Biol       Date:  2010-12-28       Impact factor: 4.292

5.  The selective progesterone receptor modulator-promegestone-delays term parturition and prevents systemic inflammation-mediated preterm birth in mice.

Authors:  Oksana Shynlova; Lubna Nadeem; Anna Dorogin; Sam Mesiano; Stephen J Lye
Journal:  Am J Obstet Gynecol       Date:  2021-08-19       Impact factor: 8.661

6.  Progesterone receptor membrane component 1 as the mediator of the inhibitory effect of progestins on cytokine-induced matrix metalloproteinase 9 activity in vitro.

Authors:  Terrence K Allen; Liping Feng; Chad A Grotegut; Amy P Murtha
Journal:  Reprod Sci       Date:  2013-06-27       Impact factor: 3.060

7.  Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.

Authors:  Agustin Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2015-10-09       Impact factor: 8.661

Review 8.  17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis.

Authors:  C A Combs; E Schuit; S N Caritis; A C Lim; T J Garite; K Maurel; D Rouse; E Thom; A T Tita; Bwj Mol
Journal:  BJOG       Date:  2015-12-10       Impact factor: 6.531

9.  The Effect of Progestins on Tumor Necrosis Factor α-Induced Matrix Metalloproteinase-9 Activity and Gene Expression in Human Primary Amnion and Chorion Cells In Vitro.

Authors:  Terrence K Allen; Liping Feng; Matthew Nazzal; Chad A Grotegut; Irina A Buhimschi; Amy P Murtha
Journal:  Anesth Analg       Date:  2015-05       Impact factor: 6.627

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.